Biocon Ltd. — Regulatory Filings 2020

Sep 30, 2020

==> picture [119 x 47] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: September 30, 2020

To The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts. Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
September 29, 2020	Sharekhan	Teleconference	Bangalore
September 30, 2020	AIA Singapore	Virtual Group Meeting	Bangalore
	Amansa Capital
	Avendus Capital
	Barings LLC
	Bellevue Asset Management
	Citi Research
	Comgest
	Eastspring Investments Singapore Ltd
	Goldman Sachs Asset Management
	Grantham Mayo
	Max Life Insurance Co Ltd
	Millenium Partners
	Mirae Asset Management
	Motilal Oswal Asset Mgmt Co Ltd
	Nikko Asset Management
	Orbimed Advisors
	Pacific Alliance Investment Mgmt
	SBI Mutual Fund
	Sparx Asset Management
	Tata AIA Life Insurance
	UTI Mutual Fund
	Wellington Management Company

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [64 x 24] intentionally omitted <==

---

==> picture [65 x 67] intentionally omitted <==

Mayank Verma

Company Secretary and Compliance Officer